Researchers have not yet studied the efficacy and safety of weight loss patches
Our retatrutide research peptide is produced with attention to purity, stability, and research-grade consistency
While the drug labels for many GLP-1 medications mentioned common side effects like nausea, vomiting, and diarrhea, it is alleged that they failed to adequately warn of the risk of developing severe, permanent conditions like gastroparesis
In 2025, the company delivered a strong +18.05% YoY revenue growth, supported by key growth drivers: Ocrevus ($8.87B) continues to lead in multiple sclerosis with sustained demand, Hemlibra ($6.01B) remains a cornerstone in hemophilia treatment, and Vabysmo ($5.19B) is rapidly scaling in ophthalmology, gaining share in retinal diseases
Our experienced medical professionals are committed to delivering personalized treatments that help you achieve your weight loss goals and feel your absolute best